108 studies found for:    "Sjogren syndrome" OR "Sjogren's Syndrome"
Show Display Options
Rank Status Study
21 Completed A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome
Conditions: Dry Eye Syndromes;   Sjögren Syndrome
Intervention:
22 Not yet recruiting Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Drug: Belimumab;   Drug: Rituximab;   Drug: Placebo belimumab;   Drug: Placebo rituximab
23 Completed Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome
Condition: Primary Sjogren's Syndrome
Intervention: Drug: Mycophenolate sodium
24 Completed Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: Hydroxychloroquine;   Drug: Placebo
25 Active, not recruiting PD of VAY736 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: VAY736;   Drug: Placebo
26 Withdrawn Study of Pharmacodynamic Effects of VAY736 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: VAY736 lower dose;   Drug: VAY736 higher dose
27 Recruiting Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: CFZ533 active;   Drug: CFZ533 placebo
28 Completed A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome
Conditions: Dry Mouth Associated With Sjogren's Syndrome;   Xerostomia
Interventions: Drug: Placebo;   Drug: 552-02
29 Enrolling by invitation Salivary Biomarkers for Sjögren's Syndrome Detection
Condition: Sjögren's Syndrome
Intervention:
30 Completed Rituximab Treatment in Sjogren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Drug: rituximab (anti-CD20)
31 Active, not recruiting Baminercept in Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Biological: Baminercept;   Other: Placebo
32 Completed Anti-CD20 Antibody Therapy for Sjogren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Drug: Rituximab
33 Completed Exploratory Study for Dry Mouth in Patients With Sjögren’s Syndrome
Conditions: Xerostomia;   Sjogren's Syndrome
Intervention: Drug: Rebamipide
34 Recruiting A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)
Condition: Sjögren's Syndrome
Interventions: Drug: LY3090106;   Drug: Placebo
35 Not yet recruiting Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome
Condition: Sjogren's Syndrome
Interventions: Drug: Cyclosporin A;   Drug: Prednisone;   Drug: Placebo;   Drug: Calcium carbonate D
36 Enrolling by invitation Confocal Microscopy and Lacrimal Gland in Sjogren's Syndrome
Condition: Primary Sjogren's Syndrome
Intervention:
37 Recruiting A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: hrIL-2 active;   Drug: hrIL-2 placebo
38 Completed Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome
Conditions: Primary Sjogren's Syndrome;   Xerostomia;   Keratoconjunctivitis Sicca;   Fatigue
Interventions: Drug: MabThera (rituximab);   Drug: Rituximab, Mabthera
39 Recruiting Efficacy of Tocilizumab in Primary Sjögren's Syndrome.
Condition: Primary Sjögren's Syndrome (pSS)
Interventions: Drug: Tocilizumab;   Drug: Placebo
40 Completed Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren's Syndrome
Condition: Sjögren's Syndrome Patients With Severe Dry Eye
Interventions: Drug: 0.02% Fm, SH;   Drug: 0.02% Fm, SH, 0.05% CsA;   Other: 0.02% Fm, SH, tBCL;   Drug: 0.02% Fm, SH, AS

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years